Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension

Journal of the American College of Cardiology

Volumn 32, Issue 2, 1998, Pages 438-443

  Sakata, Kazuyuki ^a   Shirotani, Manabu ^a   Yoshida, Hiroshi ^a   Kurata, Chinori ^b  

^a SHIZUOKA GENERAL HOSPITAL   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL; NITRENDIPINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; ESSENTIAL HYPERTENSION; HEART INNERVATION; HUMAN; MALE; PRIORITY JOURNAL; SYMPATHETIC INNERVATION; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE;

3-IODOBENZYLGUANIDINE; ADULT; AGED; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; ENALAPRIL; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HUMANS; HYPERTENSION; MALE; MEDIASTINUM; MIDDLE AGED; NITRENDIPINE; PROGNOSIS; RADIOPHARMACEUTICALS; SYMPATHETIC NERVOUS SYSTEM;

EID: 0032146284     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00261-7     Document Type: Article

References (43)

1. Esler M., Jennings G., Lambert G. Noradrenaline release and pathophysiology of primary human hypertension. Am J Hypertens. 2:1989;140S-246S.
2. Anderson E.A., Sinkey C.A., Lawton W.J., Mark A.L. Elevated sympathetic nerve activity in borderline hypertensive humans evidence from direct intraneural recordings . Hypertension. 14:1989;277-283.
3. Yamada Y., Miyajima E., Tochikubo O., Matsukawa T., Ishi M. Age-related changes in muscle sympathetic activity in essential hypertension. Hypertension. 13:1989;870-877.
4. Guzzetti S., Piccaluga E., Casati R., Cerutti S., Lombardi F., Pagani M., Malliani A. Sympathetic predominance in essential hypertension a study employing spectral analysis of heart rate variability . J Hypertens. 6:1988;711-717.
5. Rowe J.R., Troen B.R. Sympathetic nervous system and aging in man. Endocrinol Rev. 1:1980;167-179.
6. Zipes D.P., Levy M.N., Cobb L.A., Julus S., Kaufman P.G., Miller N.E., Verrier R.L. Task force 2 Sudden cardiac death . Circulation. 76:(suppl I):1987;I-202-I-207.
7. Wikstrand, J, Warnold I, Oisson G, Tuomilehto J, Eimfeldt D, Berglund G, on behalf of the Advisory Committee. Primary prevention with metoprolol in patients with hypertension: mortality results from the MAPHY study. JAMA 1988;259:1976-82.
8. Duff H.J., Mitchell L.B., Wyse D.G. Antiarrhythmic efficacy of propranolol. Comparison of low and high serum concentrations. J Am Coll Cardiol. 89:1986;959-965.
9. Waggstein F., Hjalmarson A., Varnauskas E., Wallentin I. Effects of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 37:1975;1022-1036.
10. Effects of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med. 325:1991;293-302.
11. Effects of enalapril on mortality in severe congestive heart failure results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) . N Engl J Med. 316:1987;1429-1435.
12. Van Glist W., Kingma J.H., Peels K.H., Dambrink J.H.E., Sutton M.S.J. Which patients benefit from early angiotension-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the captopril and thrombolysis study. J Am Coll Cardiol. 28:1996;114-122.
13. Zimmerman B.G., Sybertz S., Wang P.C. Interaction between sympathetic and renin angiotension systems. Hypertension. 2:1984;581-589.
14. Held P.H., Yusuf S., Furberg C.D. Calcium channel blockers in acute myocardial infarction and unstable angina an overview . Br Med J. 299:1989;1187-1192.
15. Ishikawa K., Nakai S., Takenaka T., et al. Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Circulation. 95:1997;2368-2373.
16. Frohlich E.D., McLoughlin M.J., Losem C.J., Ketelhut R., Messerli F.H. Hemodynamic comparison of two nifedipine formulations in patients with essential hypertension. Am J Cardiol. 68:1991;1346-1350.
17. Staessen J.A., Fagard R., Thijs L., et al. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 350:1997;757-764.
18. Wenzel R.R., Allegranza G., Binggeli C., Shaw S., Weidmann P., Luscher T.F., Noll G. Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine role of pharmacokinetics . J Am Coll Cardiol. 29:1997;1607-1614.
19. Cohn J.N., Levine T.B., Olivari M.T., Garberg V., Lura D., Francis G.S., Simon A.B., Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic heart failure. N Engl J Med. 311:1984;819-823.
20. Merlet P., Valette H., Dubois-Rande J.L., Moyse D., Duboc D., Dove P., Bourguignon M.H., Bevenuti C., Duval A.M., Agostini D., Loisance D., Castaigne A., Syrota A. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 33:1992;471-477.
21. Kurata C., Wakabayashi Y., Shouda S., et al. Enhanced cardiac clearance of iodine-123-MIBG in chronic renal failure. J Nucl Cardiol. 36:1995;2037-2043.
22. Sisson J.C., Wieland D.M., Sherman P., Mangner T.J., Tobes M.C., Jacques S. Jr. Metaiodobenzylguanidine as an index of adrenergic nervous system integrity and function. J Nucl Med. 28:1987;1620-1624.
23. Takatu H., Uno Y., Fujiwara H. Modulation of left ventricular iodine-125-MIBG accumulation in cardiomyopathic syrian hamsters using the renin-angiotension system. J Nucl Med. 36:1995;1055-1061.
24. Schofer J., Spielmann R., Schuchert A., Weber K., Schluter M. Iodine-123 meta-iodobenzylguanidine scintigraphy a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy . J Am Coll Cardiol. 12:1988;1252-1258.
25. Morozumi T., Kusuoka H., Fukuchi K., et al. Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med. 38:1997;49-52.
26. Imamura Y., Ando H., Mitsuoka W., et al. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol. 26:1995;1594-1599.
27. Sakata K., Yoshida H., Hoshino T., Kurata C. Sympathetic nerve activity in the spasm-induced coronary artery region is associated with disease activity of vasospastic angina. J Am Coll Cardiol. 28:1996;460-464.
28. 1993 Guidelines for the management of mild hypertension memorandum from a WHO/ISH Meeting . J Hypertens. 7:1989;689-693.
29. Shane D.J., Demur A., Chisels J., Weyman A. The committee on M-mode Standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography. Circulation. 58:1978;1072-1083.
30. Wikstrand J. Calculation of left ventricular mass in man - a comment. J Hypertens. 15:1997;811-813.
31. Schiller N.B., Shah P.M., Crawford M. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 2:1989;358-367.
32. Foli A., Kimura S., DeQuattro Lee D. Liquid-chromatographic measurement of catecholamine and metabolites in plasma and urine. Clin Chem. 33:1987;2209-2213.
33. Takeishi Y., Atsumi H., Fujiwara S., Takahashi K., Tomoike H. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med. 38:1997;1085-1089.
34. Noll G., Wenzel R.R., de Marchi S., Shaw S., Lucher T.F. Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers. Circulation. 95:1997;2286-2291.
35. Sanders J.S., Ferguson D.W. Diastolic pressure determines autonomic responses to pressure perturbation in humans. J Appl Physiol. 66:1989;800-807.
36. Story D.F., Ziogas J. Interaction of angiotensin with noradrenergic neuroeffector transmission. Trends Pharmacol Sci. 8:1987;269-271.
37. Gruber K.A., Callahan M.F., Eskridge S.S. Central administration of angiotensin II receptor antagonists and arterial pressure regulation a note of caution . Life Sci. 50:1992;1497-1502.
38. Zusman R.M. Renin- and non-renin-mediated antihypertensive actions of converting enzyme inhibitors. Kidney Int. 25:1984;969-983.
39. Malik K.U. Prostaglandins-modulation of adrenergic nervous system. Fed Proc. 37:1978;203-207.
40. Furberg C.D., Psaty B.M., Meyer J.V. Nifedipine dose-related increase in mortality in patients with coronary heart disease . Circulation. 92:1995;1326-1331.
41. Goldsmith S.R. Effect of amlodipine on norepinephrine kinetics and baroreflex function in patients with congestive heart failure. Am Heart J. 134:1997;13-19.
42. Lindqvist M., Kahan T., Melcher A., Hjemdahl P. Acute and chronic calcium antagonist treatment elevates sympathetic activity in primary hypertension. Hypertension. 24:1994;287-296.
43. 123I-metalodobenzyl guanidine imaging. J Nucl Med 1998. In press.